SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.890
-0.100 (-2.51%)
Apr 23, 2026, 2:27 PM EDT - Market open
SAB Biotherapeutics Employees
SAB Biotherapeutics had 86 employees as of December 31, 2025. The number of employees increased by 23 or 36.51% compared to the previous year.
Employees
86
Change (1Y)
23
Growth (1Y)
36.51%
Revenue / Employee
n/a
Profits / Employee
$49,550
Market Cap
273.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 23 | 36.51% |
| Dec 31, 2024 | 63 | 6 | 10.53% |
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Mar 31, 2022 | 148 | 62 | 72.09% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Sep 30, 2021 | 143 | 57 | 66.28% |
| Jun 30, 2021 | 137 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| Zentalis Pharmaceuticals | 106 |
| Artiva Biotherapeutics | 104 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Compugen | 75 |
| Cybin | 50 |
SABS News
- 1 day ago - SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 - GlobeNewsWire
- 4 weeks ago - SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 5 weeks ago - SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 5 weeks ago - SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 6 weeks ago - SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes - GlobeNewsWire
- 6 weeks ago - SAB BIO Reports Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director - GlobeNewsWire